LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$316.49
+0.95%Forward multiples
Based on analyst estimates
- P/E forward
- 28.94x
- P/E 2026E
- 32.88x
- P/E 2027E
- 25.26x
- P/E 2028E
- 21.14x
- P/S forward
- 18.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 122.20x
- PEG TTM
- 0.38x
- Price / book
- 6.58x
- Price / sales
- 24.94x
- Price / cash flow
- 69.60x
Enterprise value
- Enterprise value
- $7.0B
- EV / sales
- 27.73x
- EV / EBITDA
- 87.39x
- EV / EBIT
- 232.72x
- Market cap
- $6.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026